Lapatinib as a component of neoadjuvant therapy for HER2-positive operable breast cancer (NSABP protocol B-41): an open-label, randomised phase 3 trial

✍ Scribed by Robidoux, André; Tang, Gong; Rastogi, Priya; Geyer, Charles E; Azar, Catherine A; Atkins, James N; Fehrenbacher, Louis; Bear, Harry D; Baez-Diaz, Louis; Sarwar, Shakir; Margolese, Richard G; Farrar, William B; Brufsky, Adam M; Shibata, Henry R; Bandos, Hanna; Paik, Soonmyung; Costantino, Joseph P; Swain, Sandra M; Mamounas, Eleftherios P; Wolmark, Norman

• Book ID: 121792438
• Publisher: The Lancet
• Year: 2013
• Tongue: English
• Weight: 246 KB
• Volume: 14
• Category: Article
• ISSN: 1470-2045
• DOI: 10.1016/S1470-2045(13)70411-X